Barbara Lindheim | Consulting Vice President Investor & Public Relations |
Dale Pfost | Chairman & Chief Executive Officer |
David Weiner | Interim Chief Medical Officer |
Greetings Welcome to Chemomab Therapeutics 2022 Second Quarter Earnings Call. At this time all participants are in listen only mode. And Question-and-Answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to Barbara Lindheim, Consulting Vice President of Chemomab Therapeutics.